Transcription Factor Sp4 Regulates Dendritic Patterning During Cerebellar Maturation

Total Page:16

File Type:pdf, Size:1020Kb

Transcription Factor Sp4 Regulates Dendritic Patterning During Cerebellar Maturation Transcription factor Sp4 regulates dendritic patterning during cerebellar maturation Bele´ n Ramos, Brice Gaudillie` re, Azad Bonni, and Grace Gill* Department of Pathology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115 Edited by Huda Y. Zoghbi, Baylor College of Medicine, Houston, TX, and approved April 25, 2007 (received for review March 2, 2007) Integration of inputs by a neuron depends on dendritic arborization diverse cellular functions (26, 27). In contrast to Sp1 and Sp3, patterns. In mammals, the genetic programs that regulate dynamic which are ubiquitously expressed, Sp4 is enriched in heart and remodeling of dendrites during development and in response to skeletal muscle, with the highest levels in the brain (24, 28). Sp4 activity are incompletely understood. Here we report that knock- expression in both cardiomyogenic and neural crest lineages has down of the transcription factor Sp4 led to an increased number of been found to be important for development of the cardiac highly branched dendrites during maturation of cerebellar granule conduction system; however, the role of Sp4 in nervous system neurons in dissociated cultures and in cerebellar cortex. Time-course development remains to be elucidated (24, 28–30). analysis revealed that depletion of Sp4 led to persistent generation of In the nervous system, Sp4 mRNA is highly expressed in the dendritic branches and a failure in resorption of transient dendrites. developing hippocampus and cerebellum, in particular, in cer- Depolarization induced a reduction in the number of dendrites, and ebellar granule neurons (25). Dendritic development in cere- knockdown of Sp4 blocked depolarization-induced remodeling. Fur- bellar granule neurons occurs postnatally after these cells have thermore, overexpression of Sp4 wild type, but not a mutant lacking migrated to their final positions in the internal granule layer. the DNA-binding domain, was sufficient to promote dendritic prun- Several stages in the development of mature dendritic arbors ing in nondepolarizing conditions. These findings indicate that the have been described in granule neurons. In particular, some transcription factor Sp4 controls dendritic patterning during cerebel- intermediate stages show exuberant dendritic arbors, which are lar development by limiting branch formation and promoting activity- later remodeled to reach their mature pattern (9, 31, 32). Many dependent pruning. of the stages of cerebellar granule neuron development, includ- ing neuronal polarity and dendritic growth, are faithfully reca- branching ͉ dendrite ͉ depolarization ͉ pruning ͉ neuron pitulated in culture, which make them a reliable system to study neuronal morphogenesis (20, 33–35). he nervous system is a complex and well coordinated net- We have used cerebellar granule neurons as our experimental Twork that depends on the formation of proper connections model to investigate the role of Sp4 in postmitotic neurons. We among diverse types of neurons. Dendritic arborization patterns have found that depletion of Sp4 from granule neurons using determine the way a neuron integrates inputs. Defects in den- RNA-mediated interference (RNAi) disrupted dendritric pat- dritic patterning correlate with severe neurodevelopmental dis- terning by promoting persistent branching and impairing den- orders (1–3). Although proper dendritic arborizations are crucial dritic pruning. We report that depolarization induced a signif- for correct function of the nervous system, the genetic programs icant reduction in the number of primary and secondary that govern dendritic morphology in mammals remain poorly dendrites, and knockdown of Sp4 blocked depolarization- described. Dendritic development is a highly dynamic process induced dendritic remodeling. Furthermore, overexpression of that involves many events, including neurite outgrowth, branch- Sp4 wild type, but not a mutant lacking the DNA-binding ing, stabilization, and pruning of dendrites (4–6). There is a domain, was sufficient to restore dendritic pruning in nondepo- delicate balance between addition and elimination of neuronal larizing conditions. Our results indicate that Sp4 limits branching projections (7, 8). During development, transient overproduc- and is required for activity-dependent dendritic pruning during tion of branched dendrites appears in most neurons, after which cerebellar development. some neurites are eliminated, whereas other neurites are stabi- lized to achieve the mature pattern (9–11). Recent studies have Results described intracellular signaling pathways that operate locally to Knockdown of Sp4 Leads to Exuberant Dendritic Arborization in regulate cytoskeletal elements important for branch formation Cerebellar Granule Neurons. To investigate the function of Sp4 or elimination (12–14). in postmitotic neurons, we used RNAi to knock down Sp4 in Extrinsic factors are coordinated with cell-intrinsic, gene cerebellar granule neurons. This approach allows us to examine expression programs to determine dendritic morphology. Ge- the effects of Sp4 loss of function during a late developmental netic studies in Drosophila and Caenorhabditis elegans have window in postmitotic cells and avoids potential complications identified transcription factors that regulate diverse aspects of due to Sp4 functions in progenitor or neighboring cells, as well dendritic morphology (15–18). Transcriptional control of the as compensatory mechanisms that may act during ontogeny. fine balance between formation and elimination of processes is Morphogenesis of cerebellar granule neurons has been faithfully illustrated by the finding that, in Drosophila, the homeodomain recapitulated in vitro under depolarizing culture conditions, protein, Cut, promotes branching, whereas the BTB/POZ Zinc finger transcription, Abrupt, limits branch formation (18, 19). In mammals, the transcriptional regulators CREB, NeuroD, and Author contributions: B.R., A.B., and G.G. designed research; B.R. and B.G. performed CREST have been identified to promote dendritic growth and research; B.R. analyzed data; and B.R. and G.G. wrote the paper. branching (20–23). Transcriptional regulators that balance these The authors declare no conflict of interest. activities to restrict dendritic branching and promote pruning This article is a PNAS Direct Submission. have not been previously described in mammals. Abbreviation: DIV, days in vitro. The Zinc finger transcription factor Sp4 is highly expressed in *To whom correspondence should be addressed. E-mail: [email protected]. the developing mammalian brain (24, 25). The highly related This article contains supporting information online at www.pnas.org/cgi/content/full/ Sp1, Sp3, and Sp4 transcription factors bind to a GC box DNA 0701946104/DC1. element important for the regulation of genes that control © 2007 by The National Academy of Sciences of the USA 9882–9887 ͉ PNAS ͉ June 5, 2007 ͉ vol. 104 ͉ no. 23 www.pnas.org͞cgi͞doi͞10.1073͞pnas.0701946104 Downloaded by guest on September 24, 2021 Fig. 1. Knockdown of Sp4 transcription factor alters dendritic patterning in cerebellar granule neurons. (A) Lysates from Neuro 2A cells cotransfected with the indicated RNAi plasmid or empty vector, together with pRC-Flag-Sp4 or pRC/CMV (Vec) and GFP, were immunoblotted with antibodies against Flag and GFP. (B) Cerebellar granule neurons transfected with Scr control RNAi or the indicated RNAi targeting Sp4 and an expression plasmid encoding GFP at 2 DIV were immunostained with antibodies against GFP and Sp4 5 days posttransfection. Nuclei were stained with Hoechst. Arrowheads indicate the nucleus of a transfected neuron. (C–E) Cerebellar granule neurons were transfected as indicated in B and immunostained for GFP. (C) Representative images of neurons transfected with different RNAi constructs. Arrowhead indicates axon and asterisk cell bodies of transfected neuron, respectively. Total number of primary, secondary, and tertiary NEUROSCIENCE dendrites (D) or branching points in primary dendrites (E) was quantified. Values represent mean Ϯ SEM (ANOVA; ***, P Ͻ 0.001; **, P Ͻ 0.01; n ϭ 18–41 per condition, total n ϭ 115). For each parameter measured, neurons transfected with Scr control RNAi did not show differences compared with U6 vector alone. which support maximal health and survival of rat cerebellar tions in the Sp4 cDNA that was resistant to RNAi-mediated granule neurons; we have used these culture conditions in our knockdown (Fig. 2A). When the the Flag-Sp4 rescue vector was analysis (36–38). We generated plasmids encoding two different cotransfected with the Sp4RNAi into granule neurons, the short hairpin RNAs that specifically reduced expression of numbers of dendrites were completely restored to wild-type cotransfected FlagSp4 in Neuro 2A cells (Fig. 1A) and endog- enous nuclear Sp4 protein in cerebellar granule neurons [Fig. 1B and supporting information (SI) Fig. 7]. There was no increase in apoptosis in granule neurons transfected with either Sp4 RNAi or control as judged by the appearance of condensed chromatin 5 days after transfection (Fig. 1B and data not shown). Strikingly, we found that the dendritic morphology of neurons transfected with either of the two Sp4 RNAis was highly aberrant compared with neurons transfected with a control hairpin or RNAi for the related transcription factor Sp1 (Fig. 1C and SI Fig. 8). Immunostaining of cerebellar granule neurons for the axonal tau-1 or dendritic Map-2 proteins revealed that the major alteration in granule cells depleted
Recommended publications
  • IN COLON CANCER a Dissertation by SATYA SREEHARI PATHI Su
    MECHANISMS OF ACTION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) IN COLON CANCER A Dissertation by SATYA SREEHARI PATHI Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY August 2012 Major Subject: Toxicology MECHANISMS OF ACTION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) IN COLON CANCER A Dissertation by SATYA SREEHARI PATHI Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Approved by: Chair of Committee, Stephen H. Safe Committee Members, Robert C. Burghardt Timothy Phillips Yanan Tian Interdisciplinary Faculty Chair of Toxicology, Weston Porter August 2012 Major Subject: Toxicology iii ABSTRACT Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Colon Cancer. (August 2012) Satya Sreehari Pathi, B.V.M., Acharya N. G. Ranga Agricultural University, India; M.S., Texas A&M University, Kingsville Chair of Advisory Committee: Dr. Stephen H. Safe Non-steroidal anti-inflammatory drugs (NSAIDs) and their NO derivatives (NO- NSAIDs), and synthetic analogs are highly effective as anticancer agents that exhibit relatively low toxicity compared to most clinically used drugs. However, the mechanisms of action for NSAIDs and NO-NSAIDs are not well defined and this has restricted their clinical applications and applications for combined therapies. Earlier studies from our laboratory reported that specificity protein (Sp) transcription factors (Sp1, Sp3 and Sp4) are overexpressed in several types of human cancers including colon cancer and many Sp-regulated genes are pro-oncogenic and individual targets for cancer chemotherapy.
    [Show full text]
  • Identification of Novel Pathways That Promote Anoikis Through Genome-Wide Screens
    University of Massachusetts Medical School eScholarship@UMMS GSBS Dissertations and Theses Graduate School of Biomedical Sciences 2016-10-14 Identification of Novel Pathways that Promote Anoikis through Genome-wide Screens Victoria E. Pedanou University of Massachusetts Medical School Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss Part of the Biology Commons, and the Cancer Biology Commons Repository Citation Pedanou VE. (2016). Identification of Novel Pathways that Promote Anoikis through Genome-wide Screens. GSBS Dissertations and Theses. https://doi.org/10.13028/M27G6D. Retrieved from https://escholarship.umassmed.edu/gsbs_diss/889 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. i TITLE PAGE IDENTIFICATION OF NOVEL PATHWAYS THAT PROMOTE ANOIKIS THROUGH GENOME-WIDE SCREENS A Dissertation Presented By VICTORIA ELIZABETH PEDANOU Submitted to the Faculty of the University of Massachusetts Graduate School of Biomedical Sciences, Worcester in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY OCTOBER 14TH, 2016 CANCER BIOLOGY ii SIGNATURE PAGE IDENTIFICATION OF NOVEL PATHWAYS THAT PROMOTE ANOIKIS THROUGH GENOME-WIDE SCREENS A Dissertation Presented By VICTORIA ELIZABETH PEDANOU This work was undertaken in the Graduate School of Biomedical Sciences Cancer Biology The signature of the Thesis Advisor signifies validation of Dissertation content ___________________________ Michael R. Green, Thesis Advisor The signatures of the Dissertation Defense Committee signify completion and approval as to style and content of the Dissertation __________________________________ Eric H.
    [Show full text]
  • Supplementary Table 4
    Li et al. mir-30d in human cancer Table S4. The probe list down-regulated in MDA-MB-231 cells by mir-30d mimic transfection Gene Probe Gene symbol Description Row set 27758 8119801 ABCC10 ATP-binding cassette, sub-family C (CFTR/MRP), member 10 15497 8101675 ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2 18536 8158725 ABL1 c-abl oncogene 1, receptor tyrosine kinase 21232 8058591 ACADL acyl-Coenzyme A dehydrogenase, long chain 12466 7936028 ACTR1A ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) 18102 8056005 ACVR1 activin A receptor, type I 20790 8115490 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 15688 7979904 ADAM21 ADAM metallopeptidase domain 21 14937 8054254 AFF3 AF4/FMR2 family, member 3 23560 8121277 AIM1 absent in melanoma 1 20209 7921434 AIM2 absent in melanoma 2 19272 8136336 AKR1B10 aldo-keto reductase family 1, member B10 (aldose reductase) 18013 7954777 ALG10 asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe) 30049 7954789 ALG10B asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog B (yeast) 28807 7962579 AMIGO2 adhesion molecule with Ig-like domain 2 5576 8112596 ANKRA2 ankyrin repeat, family A (RFXANK-like), 2 23414 7922121 ANKRD36BL1 ankyrin repeat domain 36B-like 1 (pseudogene) 29782 8098246 ANXA10 annexin A10 22609 8030470 AP2A1 adaptor-related protein complex 2, alpha 1 subunit 14426 8107421 AP3S1 adaptor-related protein complex 3, sigma 1 subunit 12042 8099760 ARAP2 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 30227 8059854 ARL4C ADP-ribosylation factor-like 4C 32785 8143766 ARP11 actin-related Arp11 6497 8052125 ASB3 ankyrin repeat and SOCS box-containing 3 24269 8128592 ATG5 ATG5 autophagy related 5 homolog (S.
    [Show full text]
  • Identification of Candidate Biomarkers and Pathways Associated with Type 1 Diabetes Mellitus Using Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.08.447531; this version posted June 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karnataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2021.06.08.447531; this version posted June 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Type 1 diabetes mellitus (T1DM) is a metabolic disorder for which the underlying molecular mechanisms remain largely unclear. This investigation aimed to elucidate essential candidate genes and pathways in T1DM by integrated bioinformatics analysis. In this study, differentially expressed genes (DEGs) were analyzed using DESeq2 of R package from GSE162689 of the Gene Expression Omnibus (GEO). Gene ontology (GO) enrichment analysis, REACTOME pathway enrichment analysis, and construction and analysis of protein-protein interaction (PPI) network, modules, miRNA-hub gene regulatory network and TF-hub gene regulatory network, and validation of hub genes were then performed. A total of 952 DEGs (477 up regulated and 475 down regulated genes) were identified in T1DM. GO and REACTOME enrichment result results showed that DEGs mainly enriched in multicellular organism development, detection of stimulus, diseases of signal transduction by growth factor receptors and second messengers, and olfactory signaling pathway.
    [Show full text]
  • Target Gene Gene Description Validation Diana Miranda
    Supplemental Table S1. Mmu-miR-183-5p in silico predicted targets. TARGET GENE GENE DESCRIPTION VALIDATION DIANA MIRANDA MIRBRIDGE PICTAR PITA RNA22 TARGETSCAN TOTAL_HIT AP3M1 adaptor-related protein complex 3, mu 1 subunit V V V V V V V 7 BTG1 B-cell translocation gene 1, anti-proliferative V V V V V V V 7 CLCN3 chloride channel, voltage-sensitive 3 V V V V V V V 7 CTDSPL CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like V V V V V V V 7 DUSP10 dual specificity phosphatase 10 V V V V V V V 7 MAP3K4 mitogen-activated protein kinase kinase kinase 4 V V V V V V V 7 PDCD4 programmed cell death 4 (neoplastic transformation inhibitor) V V V V V V V 7 PPP2R5C protein phosphatase 2, regulatory subunit B', gamma V V V V V V V 7 PTPN4 protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) V V V V V V V 7 EZR ezrin V V V V V V 6 FOXO1 forkhead box O1 V V V V V V 6 ANKRD13C ankyrin repeat domain 13C V V V V V V 6 ARHGAP6 Rho GTPase activating protein 6 V V V V V V 6 BACH2 BTB and CNC homology 1, basic leucine zipper transcription factor 2 V V V V V V 6 BNIP3L BCL2/adenovirus E1B 19kDa interacting protein 3-like V V V V V V 6 BRMS1L breast cancer metastasis-suppressor 1-like V V V V V V 6 CDK5R1 cyclin-dependent kinase 5, regulatory subunit 1 (p35) V V V V V V 6 CTDSP1 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 V V V V V V 6 DCX doublecortin V V V V V V 6 ENAH enabled homolog (Drosophila) V V V V V V 6 EPHA4 EPH receptor A4 V V V V V V 6 FOXP1 forkhead box P1 V
    [Show full text]
  • Supp Data.Pdf
    Supplementary Methods Verhaak sub-classification The Verhaak called tumor subtype was assigned as determined in the Verhaak et al. manuscript, for those TCGA tumors that were included at the time. TCGA data for expression (Affymetrix platform, level 1) and methylation (Infinium platform level 3) were downloaded from the TCGA portal on 09/29/2011. Affymetrix data were processed using R and Biocondutor with a RMA algorithm using quantile normalization and custom CDF. Level 3 methylation data has already been processed and converted to a beta-value. The genes that make up the signature for each of the 4 Verhaak groups (i.e. Proneural, Neural, Mesenchymal, and Classical) were downloaded. For each tumor, the averaged expression of the 4 genes signatures was calculated generating 4 ‘metagene’ scores, one for each subtype, (Colman et al.2010) for every tumor. Then each subtype metagene score was z-score corrected to allow comparison among the 4 metagenes. Finally, for each tumor the subtype with the highest metagene z-score among the four was used to assign subtype. Thus by this method, a tumor is assigned to the group to which it has the strongest expression signature. The shortcoming is that if a tumor has a ‘dual personality’ – for instance has strong expression of both classical and mesenchymal signature genes, there is some arbitrariness to the tumor’s assignment. Western Blot Analysis and cell fractionation Western blot analysis was performed using standard protocols. To determine protein expression we used the following antibodies: TAZ (Sigma and BD Biosciences), YAP (Santa Cruz Biotechnology), CD44 (Cell Signaling), FN1 (BD Biosciences), TEAD1, TEAD2, TEAD3, TEAD4 (Santa Cruz Biotechnology), MST1, p-MST1, MOB1, LATS1, LATS2, 14-3-3-, 1 ACTG2, (Cell Signaling), p-LATS1/2 (Abcam), Flag (Sigma Aldrich), Actin (Calbiochem), CAV2 (BD Biosciences), CTGF (Santa Cruz), RUNX2 (Sigma Aldrich), Cylin A, Cyclin E, Cyclin B1, p-cdk1, p-cdk4 (Cell Signaling Technologies).
    [Show full text]
  • 1 SUPPLEMENTAL DATA Figure S1. Poly I:C Induces IFN-Β Expression
    SUPPLEMENTAL DATA Figure S1. Poly I:C induces IFN-β expression and signaling. Fibroblasts were incubated in media with or without Poly I:C for 24 h. RNA was isolated and processed for microarray analysis. Genes showing >2-fold up- or down-regulation compared to control fibroblasts were analyzed using Ingenuity Pathway Analysis Software (Red color, up-regulation; Green color, down-regulation). The transcripts with known gene identifiers (HUGO gene symbols) were entered into the Ingenuity Pathways Knowledge Base IPA 4.0. Each gene identifier mapped in the Ingenuity Pathways Knowledge Base was termed as a focus gene, which was overlaid into a global molecular network established from the information in the Ingenuity Pathways Knowledge Base. Each network contained a maximum of 35 focus genes. 1 Figure S2. The overlap of genes regulated by Poly I:C and by IFN. Bioinformatics analysis was conducted to generate a list of 2003 genes showing >2 fold up or down- regulation in fibroblasts treated with Poly I:C for 24 h. The overlap of this gene set with the 117 skin gene IFN Core Signature comprised of datasets of skin cells stimulated by IFN (Wong et al, 2012) was generated using Microsoft Excel. 2 Symbol Description polyIC 24h IFN 24h CXCL10 chemokine (C-X-C motif) ligand 10 129 7.14 CCL5 chemokine (C-C motif) ligand 5 118 1.12 CCL5 chemokine (C-C motif) ligand 5 115 1.01 OASL 2'-5'-oligoadenylate synthetase-like 83.3 9.52 CCL8 chemokine (C-C motif) ligand 8 78.5 3.25 IDO1 indoleamine 2,3-dioxygenase 1 76.3 3.5 IFI27 interferon, alpha-inducible
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0269772 A1 Califano Et Al
    US 20090269772A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0269772 A1 Califano et al. (43) Pub. Date: Oct. 29, 2009 (54) SYSTEMS AND METHODS FOR Publication Classification IDENTIFYING COMBINATIONS OF (51) Int. Cl. COMPOUNDS OF THERAPEUTIC INTEREST CI2O I/68 (2006.01) CI2O 1/02 (2006.01) (76) Inventors: Andrea Califano, New York, NY G06N 5/02 (2006.01) (US); Riccardo Dalla-Favera, New (52) U.S. Cl. ........... 435/6: 435/29: 706/54; 707/E17.014 York, NY (US); Owen A. (57) ABSTRACT O'Connor, New York, NY (US) Systems, methods, and apparatus for searching for a combi nation of compounds of therapeutic interest are provided. Correspondence Address: Cell-based assays are performed, each cell-based assay JONES DAY exposing a different sample of cells to a different compound 222 EAST 41ST ST in a plurality of compounds. From the cell-based assays, a NEW YORK, NY 10017 (US) Subset of the tested compounds is selected. For each respec tive compound in the Subset, a molecular abundance profile from cells exposed to the respective compound is measured. (21) Appl. No.: 12/432,579 Targets of transcription factors and post-translational modu lators of transcription factor activity are inferred from the (22) Filed: Apr. 29, 2009 molecular abundance profile data using information theoretic measures. This data is used to construct an interaction net Related U.S. Application Data work. Variances in edges in the interaction network are used to determine the drug activity profile of compounds in the (60) Provisional application No. 61/048.875, filed on Apr.
    [Show full text]
  • Cell Cycle Arrest Through Indirect Transcriptional Repression by P53: I Have a DREAM
    Cell Death and Differentiation (2018) 25, 114–132 Official journal of the Cell Death Differentiation Association OPEN www.nature.com/cdd Review Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM Kurt Engeland1 Activation of the p53 tumor suppressor can lead to cell cycle arrest. The key mechanism of p53-mediated arrest is transcriptional downregulation of many cell cycle genes. In recent years it has become evident that p53-dependent repression is controlled by the p53–p21–DREAM–E2F/CHR pathway (p53–DREAM pathway). DREAM is a transcriptional repressor that binds to E2F or CHR promoter sites. Gene regulation and deregulation by DREAM shares many mechanistic characteristics with the retinoblastoma pRB tumor suppressor that acts through E2F elements. However, because of its binding to E2F and CHR elements, DREAM regulates a larger set of target genes leading to regulatory functions distinct from pRB/E2F. The p53–DREAM pathway controls more than 250 mostly cell cycle-associated genes. The functional spectrum of these pathway targets spans from the G1 phase to the end of mitosis. Consequently, through downregulating the expression of gene products which are essential for progression through the cell cycle, the p53–DREAM pathway participates in the control of all checkpoints from DNA synthesis to cytokinesis including G1/S, G2/M and spindle assembly checkpoints. Therefore, defects in the p53–DREAM pathway contribute to a general loss of checkpoint control. Furthermore, deregulation of DREAM target genes promotes chromosomal instability and aneuploidy of cancer cells. Also, DREAM regulation is abrogated by the human papilloma virus HPV E7 protein linking the p53–DREAM pathway to carcinogenesis by HPV.Another feature of the pathway is that it downregulates many genes involved in DNA repair and telomere maintenance as well as Fanconi anemia.
    [Show full text]
  • Systems Genetics Identifies a Role for Cacna2d1 Regulation in Elevated
    Supplementary Dataset 1: Gene set enrichment analysis (GSEA) input Gene Symbol Gene name Score Cacna2d1 calcium channel, voltage-dependent, alpha 2/delta subunit 1 1 Pten phosphatase and tensin homolog (mutated in multiple advanced cancers 1) 0.8113829 Rora RAR-related orphan receptor A 0.7830256 Nfia nuclear factor I/A 0.77796155 Plxna2 plexin A2 0.7689365 Rwdd4a RWD domain containing 4A 0.75700486 Znf608 zinc finger protein 608 0.7334024 Huwe1 HECT, UBA and WWE domain containing 1 0.73015225 Prkg1 protein kinase, cGMP-dependent, type I 0.7254574 Rab39b RAB39B, member RAS oncogene family 0.71763426 St3gal2 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 0.70345706 Lpgat1 lysophosphatidylglycerol acyltransferase 1 0.7029922 potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia Kcna1 0.7010396 with myokymia) Ppp2ca protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform 0.69497764 Maoa monoamine oxidase A 0.6936078 Socs6 suppressor of cytokine signaling 6 0.6922545 Abcc5 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 0.6845195 Hspa4 heat shock 70kDa protein 4 0.6812371 Dctn4 dynactin 4 (p62) 0.68075943 Lats2 LATS, large tumor suppressor, homolog 2 (Drosophila) 0.67761165 Lin7a lin-7 homolog A (C. elegans) 0.673076 Itga9 integrin, alpha 9 0.6707624 Isoc1 isochorismatase domain containing 1 0.6701377 Cyfip2 cytoplasmic FMR1 interacting protein 2 0.6698394 Asip agouti signaling protein, nonagouti homolog (mouse) 0.6682124 Trpm7 transient receptor potential cation channel, subfamily M,
    [Show full text]
  • Differentially Expressed Genes Using Genomic Expression Profiles An
    Downloaded from genome.cshlp.org on July 13, 2011 - Published by Cold Spring Harbor Laboratory Press An Efficient and Robust Statistical Modeling Approach to Discover Differentially Expressed Genes Using Genomic Expression Profiles Jeffrey G. Thomas, James M. Olson, Stephen J. Tapscott, et al. Genome Res. 2001 11: 1227-1236 Access the most recent version at doi:10.1101/gr.165101 References This article cites 78 articles, 33 of which can be accessed free at: http://genome.cshlp.org/content/11/7/1227.full.html#ref-list-1 Article cited in: http://genome.cshlp.org/content/11/7/1227.full.html#related-urls Email alerting Receive free email alerts when new articles cite this article - sign up in the box at the service top right corner of the article or click here To subscribe to Genome Research go to: http://genome.cshlp.org/subscriptions Cold Spring Harbor Laboratory Press Downloaded from genome.cshlp.org on July 13, 2011 - Published by Cold Spring Harbor Laboratory Press Methods An Efficient and Robust Statistical Modeling Approach to Discover Differentially Expressed Genes Using Genomic Expression Profiles Jeffrey G. Thomas,1 James M. Olson,2 Stephen J. Tapscott,2 and Lue Ping Zhao1,3 1Division of Public Health Sciences and 2Division of Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA We have developed a statistical regression modeling approach to discover genes that are differentially expressed between two predefined sample groups in DNA microarray experiments. Our model is based on well-defined assumptions, uses rigorous and well-characterized statistical measures, and accounts for the heterogeneity and genomic complexity of the data.
    [Show full text]
  • Supplementary Figure S1 A
    Supplementary Figure S1 A B C 1 4 1 3 1 2 1 2 1 0 1 1 (Normalized signal values)] 2 (Normalized signal values) (Normalized 8 2 10 Log 6 AFFX-BioC AFFX-BioB AFFX-BioDn AFFX-CreX hDFs [Log 6 8 10 12 14 hOFs [Log2 (Normalized signal values)] Supplementary Figure S2 GLYCOLYSIS PENTOSE-PHOSPHATE PATHWAY Glucose Purine/pyrimidine Glucose-6-phosphate metabolism AMINO ACID Fluctose-6-phosphate AMPK METABOLISM TIGAR PFKFB2 methylgloxal GloI Ser, Gly, Thr Glyceraldehyde-3-phosphate ALDH Lactate PYRUVATE LDH METABOLISM acetic acid Ethanol Pyruvate GLYCOSPHINGOLIPID NADH BIOSYNTHESIS Ala, Cys DLD PDH PDK3 DLAT Fatty acid Lys, Trp, Leu, Acetyl CoA ACAT2 Ile, Tyr, Phe β-OXIDATION ACACA Citrate Asp, Asn Citrate Acetyl CoA Oxaloacetate Isocitrate MDH1 IDH1 Glu, Gln, His, ME2 TCA Pro, Arg 2-Oxoglutarate MDH1 CYCLE Pyruvate Malate ME2 GLUTAMINOLYSIS FH Succinyl-CoA Fumalate SUCLA2 Tyr, Phe Var, Ile, Met Supplementary Figure S3 Entrez Gene Symbol Gene Name hODs hDFs hOF-iPSCs GeneID 644 BLVRA biliverdin reductase A 223.9 259.3 253.0 3162 HMOX1 heme oxygenase 1 1474.2 2698.0 452.3 9365 KL klotho 54.1 44.8 36.5 nicotinamide 10135 NAMPT 827.7 626.2 2999.8 phosphoribosyltransferase nuclear factor (erythroid- 4780 NFE2L2 2134.5 1331.7 1006.2 derived 2) related factor 2 peroxisome proliferator- 5467 PPARD 1534.6 1352.9 330.8 activated receptor delta peroxisome proliferator- 5468 PPARG 524.4 100.8 63.0 activated receptor gamma 5621 PRNP prion protein 4059.0 3134.1 1065.5 5925 RB1 retinoblastoma 1 882.9 805.8 739.3 23411 SIRT1 sirtuin 1 231.5 216.8 1676.0 7157 TP53
    [Show full text]